At InVirtuoLabs, we are revolutionizing drug discovery by seamlessly integrating cutting-edge artificial intelligence with molecular simulations. Our innovative platform combines advanced machine learning techniques, including multimodal learning, active learning, and generative chemistry, with physics-based simulations to explore vast chemical spaces with unprecedented efficiency.
27.02.2026
InVirtuoLabs closes R&D agreement with Helsinn (startupticker.ch)
12.02.2026
InVirtuoLabs to lead €2.3M Eurostars grant project NEUROSPARK (startupticker.ch)
31.10.2025
More than 20 Swiss biotech companies to exhibit at Bio Europe (startupticker.ch)
28.07.2025
InVirtuoLabs unveils AI-powered platform to accelerate drug discovery (startupticker.ch)
20.02.2025
€2.85 million to accelerate AI in drug discovery (startupticker.ch)
No Jobs
InVirtuoPlatform-Overview
No Awards
Website:
www.invirtuolabs.com
Headquarter:
Lugano
Foundation Date:
July 2024
Technology: